Traduction de «a strong research base » (Néerlandais → Français) :

variation in practice which affects patient outcomes and a strong research base providing evidence of effective practice, guidelines can assist doctors and other health care professionals in making decisions about appropriate and effective care for their patients.
„They are designed to help practitioners assimilate, evaluate and implement the everincreasing amount of evidence and opinion on best current practice. Clinical guidelines are intended as neither cookbook nor textbook but, where there is evidence of variation in practice which affects patient outcomes and a strong research base providing evidence of effective practice, guidelines can assist doctors and other health care professionals in making decisions about appropriate and effective care for their patients.

Exjade (USD 182 million, +7% cc) has continued to expand with strong growth based on new patients, expanded access and increased dosing in the US and key markets around the world.
Exjade (USD 182 millions, +7% tcc) a poursuivi sa forte croissance grâce à de nouveaux malades, à un accès étendu et à une hausse du dosage moyen aux Etats-Unis et dans les principaux marchés du monde entier.

Novartis increases dividend by 25% based on strong 2008 results from strategic healthcare portfolio
Novartis augmente son dividende de 25% grâce aux excellents résultats de son portefeuille stratégique axé sur la santé

The use stakeholders involvement: 13 /16 of routine preoperative tests for elective rigour of development: 21 /28 Strong methodology, surgery. clarity and presentation:14 /16 recommendations based applicability: 6 /12 on consensus due to lack
The use stakeholders involvement: 13 /16 of routine preoperative tests for elective rigour of development: 21 /28 Strong methodology, surgery. clarity and presentation:14 /16 recommendations biased applicability: 6 /12 on consensus due to lack

2010 outlook (Barring unforeseen events) Based on the strong first half, we are raising our sales guidance for the full year.
Perspectives 2010 (sauf événements imprévus) Sur la base des excellents résultats enregistrés au premier semestre, nous relevons nos prévisions de chiffre d'affaires sur l'exercice complet.

Gleevec/Glivec (USD 3.7 billion, +15% lc), a targeted therapy for certain forms of chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST), sustained solid double-digit growth in 2008 based on strong clinical data and its status as the leading therapy for these and other life-threatening forms of cancer.
Glivec/Gleevec (USD 3,7 milliards, +15% en m. l.), traitement ciblé contre certaines formes de leucémie myéloïde chronique (LMC) et les tumeurs stromales gastro-intestinales (GIST), a conservé une croissance soutenue à deux chiffres, grâce à d’excellents résultats cliniques et à son statut de traitement de pointe pour ces maladies et d’autres formes de cancer souvent fatales.

Zoeken op de klassieke evidence based websites voor richtlijnen (Cochrane Library, US National Clearinghouse, NICE, SIGN, New Zealand Guidelines Group, National Health and Medical Research Council, Prodigy, CMA Infobase, GAC guidelines, Primary Care Clinical Practice Guidelines, AHRQ Agency for Healthcare Research and Quality, Clinical Evidence, National Library for Health (Guideline Finder), SumSearch) met de zoekterm “ ‘pneumonia’ and ‘nursing home’ “ levert geen resultaat op.
La recherche de directives sur les “evidence based websites” classiques (Cochrane Library, US National Clearinghouse, NICE, SIGN, New Zealand Guidelines Group, National Health and Medical Research Council, Prodigy, CMA Infobase, GAC guidelines, Primary Care Clinical Practice Guidelines, AHRQ Agency for Healthcare Research and Quality, Clinical Evidence, National Library for Health (Guideline Finder), SumSearch) avec les termes de recherche “ ‘pneumonia’ and ‘nursing home’ “ ne donne aucun résultat.

FoldRx is a development and discovery company focusing on first-in-class, disease-modifying, small molecule therapeutics to treat diseases of protein misfolding and aggregation (amyloidosis) based on the pioneer work of its scientific founders, Jeffery Kelly (The Scripps Research Institute) and Susan Lindquist (Whitehead Institute).
folding and its platform for drug and target discovery, the company is building a pipeline, initially for neurodegenerative and respiratory conditions. FoldRx’s pipeline includes a program in advanced clinical development to treat genetic neurologic and cardiovascular disorders, Transthyretin (TTR) Amyloid Polyneuropathy (ATTR-PN) and TTR Amyloid Cardiomyopathy (ATTR-CM), and a discovery program in cystic fibrosis, Parkinson’s, and Huntington’s disease based on its broad, proprietary, yeast-based drug discovery platform.

Evidence-based practice, Health Services Research; Mental Health Services; Organization and administration
Evidence-based practice , Health Services Research; Mental Health Services; Organization and administration

Ian Read is Chief Executive Officer en lid van de Raad van Bestuur van Pfizer, het grootste research-based biofarmaceutisch bedrijf ter wereld.
Ian Read est Président-Directeur Général de Pfizer, la plus grande société biopharmaceutique de recherche au monde, qui découvre, met au point, fabrique et commercialise un vaste portefeuille de médicaments couvrant tout le spectre des produits de santé humaine et vétérinaire.